Mark J. Mulligan

Dr. Mulligan is the Thomas S. Murphy, Sr. Professor and Director of the Division of Infectious Diseases & Immunology in the Department of Medicine at the NYU Grossman School of Medicine. He is also the Inaugural Director of the NYU Langone Vaccine Center and one of the principal investigators on the Pfizer Inc. and BioNTech COVID-19 vaccine trials. As a translational physician-scientist, he leads a research clinic and a research laboratory, which is currently dedicating its research to SARS-CoV-2. Dr. Mulligan is principal investigator for an NIH/NIAID-funded Vaccine and Treatment Evaluation Unit (VTEU) and chairs the steering committee for the NIAID-funded Collaborative Influenza Vaccine Innovation Centers (CIVICS) network. Dr. Mulligan received his M.D. from UT Southwestern Medical School and is board certified in internal medicine and infectious diseases.